Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paraoxonase 1 as a Major Bioactivating Hydrolase for Olmesartan Medoxomil in Human Blood Circulation: Molecular Identification and Contribution to Plasma Metabolism
Tomoko Ishizuka, Izumi Fujimori, Atsuko Nishida, et al.
Drug Metabolism and Disposition (2011) Vol. 40, Iss. 2, pp. 374-380
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel, Carolyn Foster, Hans R. Brunner, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 2, pp. 809-848
Closed Access | Times Cited: 271
A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development
Shingo Oda, Tatsuki Fukami, Tsuyoshi Yokoi, et al.
Drug Metabolism and Pharmacokinetics (2014) Vol. 30, Iss. 1, pp. 30-51
Open Access | Times Cited: 204
The Emerging Role of Human Esterases
Tatsuki Fukami, Tsuyoshi Yokoi
Drug Metabolism and Pharmacokinetics (2012) Vol. 27, Iss. 5, pp. 466-477
Closed Access | Times Cited: 211
Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin–ligand complexes
Ulrich Kragh‐Hansen
Biochimica et Biophysica Acta (BBA) - General Subjects (2013) Vol. 1830, Iss. 12, pp. 5535-5544
Closed Access | Times Cited: 119
Hepatic, Intestinal, Renal, and Plasma Hydrolysis of Prodrugs in Human, Cynomolgus Monkey, Dog, and Rat: Implications for In Vitro–In Vivo Extrapolation of Clearance of Prodrugs
Haruka Nishimuta, J. Brian Houston, Aleksandra Galetin
Drug Metabolism and Disposition (2014) Vol. 42, Iss. 9, pp. 1522-1531
Closed Access | Times Cited: 71
Why Great Mitotic Inhibitors Make Poor Cancer Drugs
Victoria C. Yan, Hannah E. Butterfield, Anton H. Poral, et al.
Trends in cancer (2020) Vol. 6, Iss. 11, pp. 924-941
Open Access | Times Cited: 54
Non-P450 Drug-Metabolizing Enzymes: Contribution to Drug Disposition, Toxicity, and Development
Tatsuki Fukami, Tsuyoshi Yokoi, Miki Nakajima
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 405-425
Open Access | Times Cited: 42
Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review
Dominika Kunachowicz, Milena Ściskalska, Marta Kepinská
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 2813-2813
Open Access | Times Cited: 11
PON-1 and PON-2 Polymorphisms and PON-1 Paraoxonase Activity in People Living with HIV-1
Cadiele Oliana Reichert, Débora Levy, Luciana Morganti Ferreira Maselli, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 209-209
Open Access
Medoxomil Prodrug Strategies
Ehfazul Haque, Gunda I. Georg
Journal of Medicinal Chemistry (2025)
Closed Access
Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 11, pp. 1888-1895
Closed Access | Times Cited: 29
Interspecies differences in stability kinetics and plasma esterases involved in hydrolytic activation of curcumin diethyl disuccinate, a prodrug of curcumin
Pahweenvaj Ratnatilaka Na Bhuket, Ponsiree Jithavech, Boonsri Ongpipattanakul, et al.
RSC Advances (2019) Vol. 9, Iss. 8, pp. 4626-4634
Open Access | Times Cited: 24
Management of Hypertension Using Olmesartan Alone or in Combination
Xiaoshen Zhang, Han Zhang, Yuxia Ma, et al.
Cardiology and Therapy (2017) Vol. 6, Iss. 1, pp. 13-32
Open Access | Times Cited: 22
Pharmacokinetic Interaction Between Rosuvastatin and Olmesartan: A Randomized, Open-label, 3-period, Multiple-dose Crossover Study in Healthy Korean Male Subjects
Hyerang Roh, Hankil Son, Dong Hwan Lee, et al.
Clinical Therapeutics (2014) Vol. 36, Iss. 8, pp. 1159-1170
Closed Access | Times Cited: 15
Interindividual Variability of Carboxymethylenebutenolidase Homolog, a Novel Olmesartan Medoxomil Hydrolase, in the Human Liver and Intestine
Tomoko Ishizuka, Veronika Rozehnal, Thomas M. Fischer, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 5, pp. 1156-1162
Closed Access | Times Cited: 13
Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir
Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 9, pp. 4176-4188
Closed Access | Times Cited: 13
Regulation of human hydrolases and its implications in pharmacokinetics and pharmacodynamics
Sun Min Jung, Hao‐Jie Zhu
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 11, pp. 1139-1151
Open Access | Times Cited: 1
Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response
Christián Höcht, Facundo M. Bertera, Yanina Santander Plantamura, et al.
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 15, Iss. 1, pp. 1-13
Closed Access | Times Cited: 10
Unique Hydrolysis of an Ester-Type Prodrug of Levodopa in Human Plasma: Relay-Type Role Sharing between Alpha-1 Acid Glycoprotein and Human Serum Albumin
Kenta Kono, Yukina Fukuchi, Hoshimi Okawa, et al.
Molecular Pharmaceutics (2019) Vol. 16, Iss. 10, pp. 4131-4138
Closed Access | Times Cited: 9
Investigation of the chiral recognition ability of human carboxylesterase 1 using indomethacin esters
Masato Takahashi, Daisuke Takani, Masami Haba, et al.
Chirality (2019) Vol. 32, Iss. 1, pp. 73-80
Closed Access | Times Cited: 7
Discovery of olmesartan hexetil: A new potential prodrug of olmesartan
Mohammed I. El‐Gamal, Hanan S. Anbar, Hye Jin Chung, et al.
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 5, pp. 1347-1350
Closed Access | Times Cited: 5
SIMULTANEOUS DETERMINATION OF ATORVASTATIN CALCIUM AND OLMESARTAN MEDOXOMIL IN RAT PLASMA BY LIQUID CHROMATOGRAPHY ELECTROSPRAY IONIZATION TANDEM MASS SPECTROMETRY AND ITS APPLICATION TO PHARMACOKINETICS IN RATS
Shankar Ganesh, Pragney Deme, Ramakrishna Sistla
International Journal of Pharmacy and Pharmaceutical Sciences (2014) Vol. 6, Iss. 10, pp. 464-468
Closed Access | Times Cited: 4
Evaluation of anti-inflammatory, immunomodulatory effects and celiac-like side effect of olmesartan medoxomil as a vitamin D receptor agonist and angiotensin II receptor blocker
Yelda Komesli, H. Yeşim Karasulu
Journal of Research in Pharmacy (2021) Vol. 26(1), Iss. 26(1), pp. 1080-1091
Open Access | Times Cited: 4
Genetic variation at Q192R and L55M polymorphisms in PON1
Siuli Mitra, Gautam K. Kshatriya
Environmental Toxicology and Pharmacology (2016) Vol. 45, pp. 251-256
Closed Access | Times Cited: 2
Identification of non-P450 enzymes involved in the metabolism of new drugs: Their significance in drug interaction evaluation and prodrug disposition
Yumi Nishiya, Eiko Suzuki, Tomoko Ishizuka, et al.
Drug Metabolism and Pharmacokinetics (2019) Vol. 35, Iss. 1, pp. 45-55
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top